COVID‐19 occurrence in one secukinumab‐treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus
Author:
Affiliation:
1. Dermatologia Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy
2. Dermatologia Università Cattolica del Sacro Cuore Rome Italy
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.15209
Reference5 articles.
1. Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus
2. Open‐label, investigator‐initiated, single‐site exploratory trial evaluating secukinumab, an anti‐interleukin‐17A monoclonal antibody, for patients with moderate‐to‐severe hidradenitis suppurativa
3. Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial
4. A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab
5. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Secukinumab treatment of hidradenitis suppurativa: questions remain;The Lancet;2024-02
2. Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies;Dermatology and Therapy;2023-07-04
3. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa;International Journal of Molecular Sciences;2023-05-08
4. The impact of the COVID-19 pandemic on SLE;Modern Rheumatology;2023-03-24
5. COVID-19 in systemic lupus erythematosus: A pooled analysis and systematic review of case reports and series;Lupus;2021-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3